Tags

Type your tag names separated by a space and hit enter

The impact of managed behavorial healthcare on the costs of psychiatric and chemical dependency treatment.
Behav Healthc Tomorrow. 1994 Mar-Apr; 3(2):18-30.BH

Abstract

As Congress debates the Health Security Act, a key issue centers on whether and how to include mental health and substance abuse benefits and how to contain costs if and when these benefits are paid at parity with general healthcare. Previous studies estimating the average annual cost of providing behavioral healthcare services have shown considerable divergence, depending on the nature of the defined population and the inclusion of various benefit categories, out-of-pocket expense and administrative costs. Experience from 14 members of the American Managed Behavioral Healthcare Association (AMBHA) is used to define the key features of managed behavioral healthcare, and to demonstrate that a properly managed behavioral healthcare benefit can be significantly less costly than the current reform debate would admit. AMBHA companies (which have many years of experience and presently manage the cost and quality of care for over 65 million people in the United States) [See Table 3, page 28], have shown that a specialty managed care approach can achieve not only significant savings to healthcare providers, payers and society, but also improve quality and access to care. Traditional attempts at reducing mental illness benefit coverage costs have entailed limitations on the availability or access to care. These approaches, however, ignored the larger implications to society of untreated mental illness and chemical dependency. When traditional coverages have offered more extensive benefits, they have primarily favored inpatient treatment, thus increasing costs by overemphasizing care of patients at expensive inpatient settings. AMBHA's proposed principles of healthcare reform and recommended benefit packages for behavioral healthcare can be found on page 80 of this magazine.

Authors+Show Affiliations

Medco Behavioral Care Services, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

10172255

Citation

Geraty, R, et al. "The Impact of Managed Behavorial Healthcare On the Costs of Psychiatric and Chemical Dependency Treatment." Behavioral Healthcare Tomorrow, vol. 3, no. 2, 1994, pp. 18-30.
Geraty R, Bartlett J, Hill E, et al. The impact of managed behavorial healthcare on the costs of psychiatric and chemical dependency treatment. Behav Healthc Tomorrow. 1994;3(2):18-30.
Geraty, R., Bartlett, J., Hill, E., Lee, F., Shusterman, A., & Waxman, A. (1994). The impact of managed behavorial healthcare on the costs of psychiatric and chemical dependency treatment. Behavioral Healthcare Tomorrow, 3(2), 18-30.
Geraty R, et al. The Impact of Managed Behavorial Healthcare On the Costs of Psychiatric and Chemical Dependency Treatment. Behav Healthc Tomorrow. 1994 Mar-Apr;3(2):18-30. PubMed PMID: 10172255.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The impact of managed behavorial healthcare on the costs of psychiatric and chemical dependency treatment. AU - Geraty,R, AU - Bartlett,J, AU - Hill,E, AU - Lee,F, AU - Shusterman,A, AU - Waxman,A, PY - 1994/2/7/pubmed PY - 1994/2/7/medline PY - 1994/2/7/entrez SP - 18 EP - 30 JF - Behavioral healthcare tomorrow JO - Behav Healthc Tomorrow VL - 3 IS - 2 N2 - As Congress debates the Health Security Act, a key issue centers on whether and how to include mental health and substance abuse benefits and how to contain costs if and when these benefits are paid at parity with general healthcare. Previous studies estimating the average annual cost of providing behavioral healthcare services have shown considerable divergence, depending on the nature of the defined population and the inclusion of various benefit categories, out-of-pocket expense and administrative costs. Experience from 14 members of the American Managed Behavioral Healthcare Association (AMBHA) is used to define the key features of managed behavioral healthcare, and to demonstrate that a properly managed behavioral healthcare benefit can be significantly less costly than the current reform debate would admit. AMBHA companies (which have many years of experience and presently manage the cost and quality of care for over 65 million people in the United States) [See Table 3, page 28], have shown that a specialty managed care approach can achieve not only significant savings to healthcare providers, payers and society, but also improve quality and access to care. Traditional attempts at reducing mental illness benefit coverage costs have entailed limitations on the availability or access to care. These approaches, however, ignored the larger implications to society of untreated mental illness and chemical dependency. When traditional coverages have offered more extensive benefits, they have primarily favored inpatient treatment, thus increasing costs by overemphasizing care of patients at expensive inpatient settings. AMBHA's proposed principles of healthcare reform and recommended benefit packages for behavioral healthcare can be found on page 80 of this magazine. SN - 1063-8490 UR - https://www.unboundmedicine.com/medline/citation/10172255/The_impact_of_managed_behavorial_healthcare_on_the_costs_of_psychiatric_and_chemical_dependency_treatment_ L2 - https://medlineplus.gov/childmentalhealth.html DB - PRIME DP - Unbound Medicine ER -